Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
5.65
+0.05 (0.89%)
At close: May 6, 2026, 4:00 PM EDT
5.60
-0.05 (-0.88%)
After-hours: May 6, 2026, 6:09 PM EDT
Atea Pharmaceuticals Market Cap
Atea Pharmaceuticals has a market cap or net worth of $452.15 million as of May 6, 2026. Its market cap has increased by 84.85% in one year.
Market Cap
452.15M
Enterprise Value
151.17M
1-Year Change
84.85%
Ranking
Category
Stock Price
$5.65
Market Cap Chart
Since the IPO on October 30, 2020, Atea Pharmaceuticals's market cap has decreased from $1.94B to $452.15M, a decrease of -76.67%. That is a compound annual growth rate of -23.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 448.15M | 60.68% |
| Dec 31, 2025 | 278.91M | -1.43% |
| Dec 31, 2024 | 282.95M | 11.19% |
| Dec 29, 2023 | 254.48M | -36.48% |
| Dec 30, 2022 | 400.61M | -46.08% |
| Dec 31, 2021 | 742.94M | -78.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prelude Therapeutics | 476.62M |
| ADC Therapeutics | 468.06M |
| Fulcrum Therapeutics | 467.77M |
| Climb Bio | 462.88M |
| PureTech Health | 460.34M |
| Eupraxia Pharmaceuticals | 455.69M |
| Vanda Pharmaceuticals | 454.62M |
| Assembly Biosciences | 442.13M |